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Abstract 
Background: Returning to, and staying in, work following illness is associated with better 
physical and psychological functioning. Not working has been shown to be associated with 
reduced self-esteem, lowered self-efficacy and decreased belief in one's ability to return to the 
workplace. Although there is a growing body of research looking at what predicts return to 
work following cancer treatment, there are fewer studies examining interventions targeting 
return to work.  
Objective: The primary objective is to assess the feasibility and acceptability of a theoretically-
led workbook intervention designed to support cancer patients in returning to work, to inform 
a fully-powered randomised controlled trial.  
Methods: This is a multi-centre feasibility randomised controlled trial, where the main analysis 
utilises a qualitative approach. Sixty participants (aged 18-65 years) who have received a 
diagnosis of cancer and who intend to return to work will be randomised into either the 
WorkPlan intervention group or a usual care group (ratio 1:1). Participants in the intervention 
group will receive a guided workbook (which contains activities aimed at eliciting thoughts and 
beliefs, identifying targets and actions and concrete steps to achieve goals) and will receive 
telephone support over a four week period. The primary outcome measure is time taken to 
return to work (in days), and secondary outcome measures include mood, quality of life, illness 
perceptions and job satisfaction. Data will be collected through postal questionnaires 
administered immediately post-intervention and at 6 and 12 month follow-ups. In addition, 
interviews will be undertaken immediately post-intervention (to explore acceptability of the 
intervention and materials) and at 12 month follow-up (to explore perceptions of participation 
in the trial and experiences of returning to work). 
Discussion: Currently no standardised return to work intervention based on targeting cancer 
patients’ beliefs is in existence. If shown to be feasible and acceptable the results will inform a 
future full randomised controlled trial and has the potential to provide a valuable and cost-
efficient tool in supporting cancer survivors in the return to work process.  
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 
ISRCTN56342476 
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Introduction 
Returning to, and staying in, work following illness is associated with better physical and 
psychological functioning. Not working has been shown to be associated with reduced self-
esteem, lowered self-efficacy and decreased belief in one's ability to return to the workplace 
[1]. Employment is important not only for individual and societal economic reasons [2] but 
because being out of work is thought to cause, contribute to and aggravate adverse health 
outcomes [3,4]. Furthermore, work is an important component of quality of life [5]. The 
observed relationship between unemployment and negative health outcomes is thought to be 
mediated by factors such as socioeconomic status, financial anxiety and a stress pathway 
involving physical changes including hypertension and lowered immunity [6,7]. Although there 
is a growing body of research looking at what predicts return to work (most commonly defined 
as returning to work quicker and improved self-reported ability to undertake one's role, 
termed workability) following cancer treatment, there are fewer studies examining 
interventions targeting return to work.  
 
Over 100,000 people of working-age receive a diagnosis of cancer each year in the United 
Kingdom (UK) [8]. Earlier diagnosis and improvements in treatment survival rates have led to 
an increase in the number of cancer survivors. UK policy reviews have highlighted a need for 
more research into the challenges of living with cancer [9,10]. For many cancer survivors 
returning to work is a realistic outcome. Many patients do well following treatment, however, 
some experience ongoing negative outcomes from the disease or treatment (including pain, 
fatigue and low mood), which may impact on everyday functioning, including work [11]. Over a 
quarter of cancer survivors report high symptom burden one year post-diagnosis, even after 
treatment termination [12]. In addition, many cancer survivors still undergo some form of 
treatment/monitoring for substantial periods of time following termination of active 
treatment. Return to work rates of between 23% and 75% have been reported [13] and cancer 
patients are 1.4 times more likely to be unemployed than healthy individuals [4]. Furthermore, 
return to work rates have been shown to vary across cancer types [14] and longer return to 
work times have been reported among patients undergoing certain treatments 
(surgery/chemotherapy) [15], experiencing fatigue [16] or reporting a non-supportive work 
environment [17]. Although some cancer types have a high return to work rate we know that 
across cancer types we see a significant proportion of patients return to work too early or in an 
  
4 
 
inappropriate manner, which results in them taking additional sick leave or leaving the 
workplace [16]. In addition, a large proportion of cancer patients report modifications in 
working hours, wages and work patterns as well as reporting perceived reductions in 
workability [13]. Cancer survivors have been shown to have similar work-disability levels to 
those reported in other chronic conditions (i.e. stroke, diabetes, heart disease, arthritis) but 
significantly higher work-disability levels when compared with age-matched adults with no 
reported chronic condition [18]. This supports the finding that cancer survivors often report 
difficulties in achieving productivity levels similar to healthy counterparts [19].  
 
Predictors of longer time to return to work include a range of disease and treatment, work-
related and psychological factors [20]. The relative role of each of these factors is difficult to 
determine, primarily because few studies directly compare these factors or studies focus on 
either a single cancer type or a mixed-cancer sample. However, a recent study [14] examined 
these factors across four distinct cancer types and identified that, in addition to optimal 
symptom management and appropriate workplace adaptations, specific cancer (e.g. holding 
negative beliefs about the consequences of cancer) and treatment-related perceptions (beliefs 
about controlling the effects of cancer at work) predicted return to work. 
 
Cancer patients have reported apprehensions about returning to work, related to concerns 
about ongoing treatments and concerns about their level of physical fitness [21]. Depressive 
symptoms are also associated with reduced return to work rates and both partial and full 
resumption of work may help alleviate depressive symptoms by challenging dysfunctional 
beliefs [22]. Research from non-cancer disease groups also supports the importance of 
psychological factors in the return to work process. Among patients diagnosed with coronary 
heart disease, depression has been shown to impact on functional recovery and to predict 
failure or delay in returning to work [23,24]. Other psychological factors such as illness 
perceptions are also predictive of reemployment and occupational functioning [25,26,27] as 
are perceptions of work-related disability (independent of physician report of disability) [28]. 
 
Specifically, in the field of cancer a number of intervention and trial protocols have been 
published. Such interventions include a 12 week occupational physician led intervention 
focused on increasing physical activity in cancer survivors to support return to work [29]; a 
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case management approach focusing on signposting/referring patients to services (e.g. 
physiotherapy, occupational or psychological therapy) that may support return to work [30]; 
and a tool that cancer survivors use to guide discussions about working [31]. Although this tool 
was initially well received it focused on guiding questions during interactions with 
employers/healthcare professionals and not on beliefs and barriers that impact on workability 
and work behaviour. In addition, a recent Cochrane systematic review identified the need for 
more high-quality randomised controlled trials (RCT’s) to enhance return to work among 
cancer patients [32]. Moreover, a recent a meta-synthesis of qualitative research studies 
highlighted the need for vocational interventions with cancer patients to be person-centred 
and for such interventions to acknowledge the role of social, clinical and work-related factors 
[33].  
 
Current study  
Feasibility studies are conducted before a main study and are used to estimate key parameters 
to support the design a full RCT [34]. This feasibility randomised controlled study will trial and 
evaluate the WorkPlan guided workbook intervention, which is a theoretically-led intervention 
aimed at targeting known psychological factors to improve work-related outcomes among 
cancer survivors. The primary objective of the study is to trial the workbook intervention and 
data collection materials, to ensure that the materials are acceptable to participants and that 
participants are able to provide full answers. This objective will be met through five aims. 
Aim 1: Trial data collection materials to ensure that the materials are acceptable to 
participants. We will identify whether the materials are acceptable to participants and that 
participants understand and are able to complete the required tasks. 
Aim 2: Trial the recruitment process and feasibility of recruiting participants into the study. We 
will observe whether we are able to meet the required monthly recruitment targets, identify 
which methods of recruitment are most successful in attracting participants into the study and 
determine if changes could be made to future studies to improve recruitment. 
Aim 3: Test the acceptability among participants of the randomisation process. As part of the 
final interview process we will discuss the randomisation process with participants to 
determine the level of understanding regarding this process and satisfaction with the 
information provided about the randomisation process. 
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Aim 4: Determine retention in control and intervention groups. We will observe the retention 
rates in the control and intervention groups to the 12-month follow-up. Where possible we will 
aim to determine reasons for attrition in both arms. 
Aim 5: Conduct the ground work necessary to obtain data that will be required in the definitive 
trial to enable a full cost-effectiveness analysis. Measures to be used in a full trial will be 
administered for acceptability.  
 
The study is funded by the National Institute for Health Research (NIHR), and registered with 
the UK Clinical Research Network (UKCRN ID: 19013). Ethical approval for this study has been 
obtained from West Midlands – Solihull (NRES) Research Ethics Committee (Reference: 
15/WM/0166), and the study is registered with the International Standard Randomized 
Controlled Trial Number (ISRCTN) registry [ISRCTN56342476]. The Protocol Version is v4.1 date 
11.11.2015. The recruitment status is open (participants are currently being recruited and 
enrolled into the study). 
 
Method 
Eligibility Criteria 
Inclusion criteria: Patients who have received a diagnosis of breast, gynaecological, urological 
or bowel cancer (which has not been classified as metastatic disease or recurrence); are at 
least two weeks post treatment initiation; are aged between 18 and 65 years; were working at 
the time of diagnosis and who are not currently working but intend to return to work.  
  
Participants will be recruited to the study from multiple UK hospital sites. We aim to recruit 60 
participants to the whole study, who will be randomised into either the intervention or the 
usual care group. There are currently no clear guidelines for estimating an appropriate sample 
size for feasibility studies. This is not a hypothesis testing study and therefore the sample size is 
based on pragmatic assumptions around feasible recruitment figures and the number of 
participants required to estimate the key parameters around the feasibility of a full RCT. 
 
WorkPlan Intervention 
The WorkPlan package is theoretically led and based around the Self-Regulation Model [35] 
and Goal Setting Theory [36], which have been applied previously in return to work 
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interventions. The intervention was developed using an intervention mapping methodology. 
This methodology is used for designing and implementing complex interventions or programs 
(interventions that comprise a number of separate elements that are essential to the 
functioning of the intervention as a whole). The WorkPlan intervention is delivered as a 4-week 
guided workbook intervention, consisting of structured sections and activities to provide 
guidance and support to patients. These structured sessions are broken down into 4 chapters 
which participants are encouraged to work through during each week of the intervention 
period. The workbook comprises activities aimed at eliciting thoughts/beliefs, identifying 
targets/actions and concrete steps to achieve goals, and leads to participants creating a 
“return to work plan” in the fourth and final week, incorporating all elements from the 
workbook into a personal return to work plan. A resources section is also included to signpost 
participants towards relevant avenues of further support. Multiple copies of the plan page will 
be available to encourage changes to be made when necessary, and these plans can be used as 
a tool when meeting with employers to aid discussion around returning to work. An 
intervention manual has also been developed in tandem with the workbook, to be used by the 
researchers alongside the delivery of the intervention.  
 
Intervention group 
Patients in the intervention group will be guided through the initial exercises and given a 
detailed overview of the workbook. They will be encouraged to discuss the workbook with 
their partner, family or friends. Two and four weeks later telephone support discussions will be 
made by the researchers to discuss progress. The workbook is used during the introductory 
session, at home during the intervention period and as a reminder during the return to work 
process.  
 
Usual care group 
Participants will receive usual care which focuses on clinical care and optimal symptom 
management, and will be offered the workbook at the end of the study. In order to prevent 
participants from undertaking activities within the workbook the following precautions have 
been included in the design: (1) the information sheets and the pre-randomisation discussion 
do not include the content or the focus of the intervention and (2) the workbook will not be 
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available to view and will only be provided following the 12 month follow-up time-point for 
that patient.  
 
Participants in either group may access other information and support relating to work post-
treatment, but will be asked to record any resources or information they receive or access 
during the trial. 
 
Procedure 
Potential participants will be recruited when they are at least two weeks post treatment 
initiation (Figure 1).  Patients will be identified through breast cancer, gynaecological cancer, 
colorectal cancer or urological cancer clinics, through multidisciplinary team meetings and by 
placing posters in clinics, chemotherapy suites and computerised tomography (CT) scan waiting 
areas. Clinicians will have leaflets and information packs (outlining the study and providing 
contact details) available for patients. Study materials have been translated into the five most 
commonly used languages among people of working age in Birmingham, according to the 2011 
Census (Bengali, Chinese (standard), Polish, Punjabi and Urdu). Interpreters will be provided if 
required.  
 
Through all routes potential participants will be provided with contact details for the 
researchers and asked to contact one of the researchers by telephone or email. Details for the 
project website will also be displayed on the leaflets and posters, where potential participants 
can access further information about the study. Participants who express interest in the study 
will be provided with an information sheet and eligibility screening questionnaire. Eligible 
patients will be sent an invitation to attend an assessment interview at the hospital or over the 
telephone, where a researcher will outline the study and randomisation process, explain the 
patient information sheet and obtain written consent (if explained via telephone, researchers 
will obtain verbal consent after explaining the study and will ask participants to return a 
written consent form via post). If participants provide additional consent, the researchers will 
inform their general practitioner (GP) about their participation in the study. Participants will 
receive £20 when they complete the assessment interview, to cover their time and any travel 
expenses. 
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Allocation and Stratification. 
The researchers will randomise participants into one of the two arms using a central online and 
text system, Sealed Envelope [37], at a ratio of 1:1 between the intervention group and usual 
care group. During the randomisation process participants will be stratified by age (18-50 or 
51-65) and cancer type (breast, bowel, gynaecological or urological). Patients with different 
cancer diagnoses may have specific impairments or side effects due to the location of the 
cancer or the treatments received. Hence, stratifying for cancer type balances out any effects 
that might be due to this variable. Treatments undertaken during the follow-up period will be 
monitored in both arms of the trial. Participants are informed about their group allocation 
(guided intervention or usual care), and participants allocated to the usual care group will be 
informed that they will be offered the workbook after the 12 month follow-up. 
 
Blinding 
The researchers will be aware of group allocation at randomisation and during follow-up, in 
order to provide telephone support to participants in the intervention group. However, the 
Principal Investigator will be blind to participant group allocation to reduce bias when 
analysing data. 
 
Data Collection Methods 
Study Outcomes 
The main outcome measures of a full RCT will be used (e.g. time to return to work). At each 
time-point participants will be asked to recall the date of return to work (paid or unpaid 
employment, whether a different job, reduced hours/salary, full-time or part-time). Any 
changes in working status/duties will be documented as will specific reasons for non-return to 
work (e.g. unavailability of job, ongoing medical concerns) to determine whether to 
incorporate these into a full trial. Secondary outcome measures include mood, satisfaction 
with return to work and satisfaction with the return to work process. Although not appropriate 
for a feasibility trial we would aim to undertake sub-group analysis of the primary outcome 
measure by cancer type/site in a future definitive RCT. 
 
Data will be collected at four time points during the study: at baseline and four-week (post-
intervention), six-month and 12-month follow-ups. At each time-point participants will 
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complete questionnaires comprising (1) Illness Perceptions Questionnaire – Revised [38], (2) 
Brief Illness Perception at Work Scale [39], (3) Hospital Anxiety and Depression Scale [40], (4) 
Work Ability Index [41], (5) Single item of satisfaction with return to work (if returned to work), 
(6) Satisfaction with Work Scale [42] (if returned to work), (7) EQ-5D-5L (Quality of Life) [43] 
and (8) Visual Analogue Scale measure of Quality of Life (single item) [44]. Questionnaire packs 
will be posted to participants with a pre-paid self-addressed envelope. In addition, participants 
will be asked to provide details of their use of services and information utilised through a text-
based service, which participants will be able to respond to via text message. A maximum of 
four text messages will be sent to each participant at the end of each month for the duration 
of the study, to gather information on their current work status and healthcare utilisation. 
Monthly questions were chosen as research shows that memory for GP appointments is 
around four weeks, and therefore we could not rely on accurate recall if healthcare utilisation 
was only recorded at six-monthly follow-ups [45,46]. The text-based service can also be used 
for reminders to participants to complete and return questionnaire packs if there is missing 
data. 
 
Interviews 
Twenty participants in the intervention group will be asked to undergo a post-intervention 
(intervention group) and 12-month post randomisation interview (intervention and usual care 
groups). Participants will be asked to participate sequentially until the recruitment target is 
reached. Interviews will be conducted over the telephone or face to face, depending on the 
participant's preference. The post-intervention interview schedule will focus on gaining 
perceptions of (1) how the intervention was delivered, (2) aspects of the intervention which 
individuals found useful and (3) compliance with the intervention, how aspects of the 
intervention were utilised and recommendations for change. The 12 month interview schedule 
will include twenty participants from both the intervention and usual care groups. These 
interviews will explore (1) experiences of the randomisation process, (2) general perceptions of 
the trial, and (3) the personal return to work process of each individual. Both groups will be 
asked about their experience of being part of either the intervention or usual care group and 
how this may have impacted on their return to work as well as any additional support received 
regarding return to work.  
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Data Management 
To maintain confidentiality all participants will be given a unique identifier which will be used 
on all hard copy and database records. Patient names will not be used. Clinical and research 
government guidelines will be followed for safe and confidential storage of participant 
personal data (such as password protected data files), which only the research team directly 
involved in the study will have access to. If a participant chooses to withdraw from the study, 
identifiable data which has already been collected with consent would be retained and used in 
the study, but no further data would be collected from the participant. 
 
Analysis plan 
Qualitative analysis 
Although this is a mixed methods study the main focus of the analysis of the study will be 
qualitative. Interviews will be recorded, transcribed verbatim and analysed using Framework 
analysis [47] to identify emergent themes. 
 
Quantitative analysis 
The purpose of this feasibility study is not hypothesis testing. Furthermore, it is anticipated 
that the sample size will be underpowered to undertake the full analysis that would be utilised 
in a full trial (Analysis of Covariance (ANCOVA) adjusting for baseline values). Baseline 
characteristics will be reported as mean and standard deviations or medians and interquartile 
ranges for continuous data and as n (%) for categorical data. Differences between the 
intervention and control groups for the primary outcome measure will be examined. 
Secondary outcome measures will be assessed using independent samples t-tests (significance 
level set at 0.05). 
 
Economic analysis 
Although an economic evaluation is not suitable in the context of a feasibility trial we will 
undertake a descriptive economic analysis focusing on the resource usage of the intervention 
(intervention materials, time, follow-ups/support), self-reported indirect costs including days 
of sickness payments/unemployment benefit and healthcare utilisation. The EQ-5D-5L will be 
used to inform the changes in quality of life over time, and these can ultimately contribute to 
the calculation of quality-adjusted life years (QALYs) in a full economic evaluation. 
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Data Monitoring 
This is a feasibility, rather than a full trial and so a data monitoring committee will not be 
convened. However, the project steering committee will review safety and efficacy data 
throughout the trial. Personal data will be accessed by the research team only, and will be 
stored or accessed for between 6 and 12 months after the study has ended. 
 
Ethics 
Ethical approval for this study has been obtained from West Midlands – Solihull (NRES) 
Research Ethics Committee (Reference: 15/WM/0166). Although we do not envisage the need 
for protocol modifications, any amendments to the protocol will be communicated to the 
research team by the Principal Investigator and if relevant to the trial participants, the 
researchers will inform them via post. 
 
Harms 
As the trial focuses on a workbook based intervention aimed at promoting return to work, we 
do not envisage any adverse events or a need to stop the trial prematurely. It is unlikely that 
the intervention would cause distress, although participants may experience distress while 
discussing their work in the context of having experienced cancer. However, procedures will be 
in place for participants to access other psychological support services if required. 
 
Dissemination Policy 
Results from the study will be reported and disseminated through publication in peer-reviewed 
scientific journals and presentations at relevant conferences. Participants will be asked to 
indicate if they would like a lay summary of the findings of the study, which will then be posted 
or emailed to them. 
 
Discussion 
There is currently no available standardised return to work intervention focused on targeting 
cancer patients’ beliefs. Previous research [48,49] has demonstrated that both cancer patients 
and organisations report that such an intervention would be invaluable to facilitating return to 
work and ensuring work retention. Undertaking a feasibility study is critical to inform the 
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planning of a larger, fully-powered randomised controlled trial to improve work-related 
outcomes among cancer survivors. The results of the study will be used to modify the trial 
materials and methodology (if required) and to determine likely recruitment and retention 
rates for a larger trial. Furthermore, if appropriate, the results of the feasibility study will be 
used to inform a sample size calculation for a future (appropriately powered) randomised 
controlled trial of the intervention with a longer follow-up period. If a future fully powered RCT 
were to demonstrate that the WorkPlan intervention is more effective in supporting return to 
work than usual care then this will allow us to implement an effective and deliverable 
intervention, providing a valuable, yet cost-efficient tool in supporting people who have 
received a diagnosis of cancer in planning and achieving supported return to work, and greater 
satisfaction with work and the return to work process.  
 
Methodological considerations 
One strength of this study is that it utilises a theoretically based intervention. The study follows 
the best practice guidelines set out by the Medical Research Council (MRC) in the development 
and evaluation of complex interventions [50] and published recommendations for pilot studies 
[51-54]. The intervention package was developed in several stages. A review of the literature 
identified that few studies focusing on return to work had targeted participants’ beliefs and yet 
the role of beliefs in the performance of numerous behaviours, including return to work, has 
previously been documented [55,56]. Following on from this a prospective questionnaire study 
was developed and administered to identify which clinical, work-related and psychological 
variables influence the return to work process among cancer patients. As part of this study 
qualitative interviews were also undertaken to gain further information about the patients’ 
vocational aspirations, perceptions of the process of returning to work and beliefs regarding 
their ability to return to work. The study demonstrated the role played by illness perceptions 
and beliefs about the impact of illness on return to work, as well as differences in predictive 
factors across cancer types [14,57,58]. The results of this research were used to map the 
intervention components through an intervention mapping methodology. This methodology is 
used for designing and implementing complex interventions or programs (interventions that 
comprise a number of separate elements that are essential to the functioning of the 
intervention as a whole). It has been used for over 20 years for systematically designing 
multifaceted programs involving numerous interventions directed at various individuals and 
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environments [59]. This methodology is suited to the development of a return to work 
programme as this is a complex intervention, requiring a tailored and multifaceted approach. 
Further strengths of the study include that the chosen self-reported outcome measures relate 
directly to the components addressed through the intervention, that resources are available to 
support a diverse sample within the study and that a qualitative analysis approach will be 
utilised. Qualitative methods are increasingly applied in the developmental stages of 
randomised controlled trials of complex interventions [59]. Qualitative methods are often used 
to help understand participants’ understanding and experience of an intervention. Individual 
in-depth interviews allow exploration of why some participants may respond more positively 
to the intervention and what modifications to the intervention may be required to suit 
different groups of participants (for example there may be differences between cancer types 
and occupation types, as well as specific gender based needs). 
 
Conclusion 
The study may be the first step in the development of several long-term benefits and may have 
some immediate benefits for the sample who participate in this feasibility study. The 
intervention will provide cancer survivors with the skills and confidence to manage their return 
to work. The intervention may improve long-term job retention among cancer survivors with 
the potential also to be adapted for other conditions. Furthermore, the intervention may have 
long-term implications for improving psychological outcomes among cancer survivors through 
improvements in well-being, mood and physical functioning, all of which could impact on the 
utilisation of National Health (NHS) services. 
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Figure 1: Study flowchart showing allocation to groups 
 
 
